Faculty

Institution

Unit

Venue

Joseph Lewnard

Associate Professor Assistant Professor

University of California, Berkeley

Affiliations

School of Public Health

Joseph Lewnard is currently serving as a School Of Public Health Associate Professor Assistant Professor at University of California, Berkeley.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Joseph Lewnard

University of California, Berkeley

Associate Professor Assistant Professor

You can click a keyword to filter the displayed items

public health epidemiology respiratory medicine infectious diseases vaccination virology clinical epidemiology infection control veterinary medicine covid-19 clinical microbiology global health vaccines sars-cov-2 emerging infectious diseases respiratory infections virus epidemiology clinical infectious disease clinical infection vaccine research infectious disease modelling disease transmission vaccine efficacy covid-19 pandemic united states laboratory medicine disease outbreaks international health tropical medicine applied microbiology retrospective cohort studies cohort studies vaccine development antibiotic use preventive medicine laboratory investigation virus transmission prospective cohort studies disease prevention infectious respiratory disease medical virology chronic viral infections vaccine hesitancy pathogen transmission disease surveillance hospital epidemiology diagnostic microbiology transmission dynamics regional studies higher education venereology antimicrobial stewardship clinical outcomes systematic review older adults low-resource settings monterey county vaccine effectiveness sexual health communicable diseases plo biology digestive diseases disease control antibiotic resistance later adulthood pediatric gastroenterology traveler diarrhea laboratory management disease progression vaccine direct effects observational studies mrna-based vaccines general population school closures birth cohort studies clinical profile computational epidemiology infectious diseases (medical specialty) bayesian analysis antimicrobial resistance epidemiological principle

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Association of Pneumococcal Conjugate Vaccination With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Older Adult Recipients of Coronavirus Disease 2019 Vaccines: A Longitudinal Cohort Study. The Journal of Infectious Diseases (2024)

Joseph A LewnardVennis HongLindsay R GrantBradley K AckersonKatia J BruxvoortMagdalena PomichowskiAdriano ArguedasAlejandro CanéLuis JodarBradford D GessnerSara Y Tartof

vaccinationcovid-19vaccinesinfection controlcovid-19 pandemicinfectious diseasesclinical infectious diseaseolder adult recipientssars-cov-2respiratory infectionsdisease outbreakspneumococcal conjugate vaccinationinfectious respiratory diseasepublic healthlongitudinal cohort studyepidemiology

Burden of Bacterial Antimicrobial Resistance in Low-Income and Middle-Income Countries Avertible by Existing Interventions: An Evidence Review and Modelling Analysis. The Lancet (2024)

Joseph A LewnardEsmita CharaniAlec GleasonLi Yang HsuWasif Ali KhanAbhilasha KarkeyClare I R ChandlerTapfumanei MasheEjaz Ahmed KhanAndre N H BulabulaPilar Donado-GodoyRamanan Laxminarayan

global healthevidence reviewmiddle-income countriesmodelling analysispublic healthhealth policyinternational healthinfectious disease modellingantimicrobial resistancebacterial antimicrobial resistance

Covid-19 Vaccination and Incidence of Pediatric Sars-Cov-2 Infection and Hospitalization. JAMA Network Open (2024)

Jennifer R. HeadPhilip A. CollenderTomás M. LeónLauren A. WhiteSohil R. SudSimon K. CamponuriVivian LeeJoseph A. LewnardJustin V. Remais

virus epidemiologyvaccinationvirologycovid-19vaccinespediatricssars-cov-2respiratory medicinepublic healthepidemiology

Dynamics of Indirect Protection Against Sars-Cov-2 Infection Through Vaccine and Infection-Acquired Immunity. medRxiv (Cold Spring Harbor Laboratory) (2024)

Sophia T. TanIsabel Rodríguez-BarraquerAda T. KwanSeth BlumbergHailey J. ParkJustine HutchinsonDavid LeidnerJoseph A. LewnardDavid SearsNathan C. Lo

vaccinationvaccinescovid-19vaccine developmentinfection controlinfectious diseasesindirect protectioninfection-acquired immunitysars-cov-2immunologyimmunity (medicine)public healthvaccine designvaccine safetyvirus research

Ensuring Progress on Sustainable Access to Effective Antibiotics at the 2024 Un General Assembly: A Target-Based Approach. The Lancet (2024)

Marc MendelsonJoseph A LewnardMike SharlandAislinn CookKoen B PouwelsYewande AlimiMirfin MpunduEvelyn WesangulaJeffrey Scott WeeseJohn-Arne RøttingenRamanan Laxminarayan

infection controldrug resistanceantimicrobial stewardshipantimicrobial resistanceapplied microbiologyantibiotic resistanceantimicrobial susceptibilityclinical microbiologyinternational healthantimicrobial agentspublic healthsustainable accesspharmacoepidemiologyeffective antibioticsantibioticsun general assemblyglobal healthhealth policysustainable healthcare

Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Lower Respiratory Tract Disease. JAMA Network Open (2024)

Sara Y. TartofNegar AliabadiGabriella GoodwinJeff SlezakVennis HongBradley AckersonQing LiuSally ShawSabrina WelshJulie A. SternBanshri KapadiaBrigitte C. SpenceJoseph A. LewnardGregg S. DavisMichael AragonesMichael DutroErica ChilsonElisa GonzalezRobin HublerBrandon ChiaLuis JodarBradford D. GessnerElizabeth Begier

vaccinationvaccinesinfectious diseasesvaccine effectivenessrespiratory medicineinfectious respiratory diseasepublic healthvaccine safetyvaccine efficacy

Health Economic Burden Attributable to Novel Serotypes in Candidate 24- and 31-Valent Pneumococcal Conjugate Vaccines. medRxiv (Cold Spring Harbor Laboratory) (2024)

Laura M KingJoseph A Lewnard

vaccinationhealth economicsvaccinesvaccine developmentveterinary medicineinfectious diseaseslaboratory medicinepublic healthhealth sciences

Health-Economic Burden Attributable to Novel Serotypes in Candidate 24- and 31-Valent Pneumococcal Conjugate Vaccines. Vaccine (2024)

Laura M KingJoseph A Lewnard

vaccinationvaccinesvaccine developmenthealth-economic burdennovel serotypespublic healthvaccine research

Immune Escape and Attenuated Severity Associated With the Sars-Cov-2 Ba.2.86/Jn.1 Lineage. Nature Communications (2024)

Joseph A LewnardParag MahaleDebbie MaldenVennis HongBradley K AckersonBruno J LewinRuth Link-GellesLeora R FeldsteinMarc LipsitchSara Y Tartof

virologycovid-19immune escapeinfectious diseasesmicrobial pathogenesissars-cov-2immunologyviral pathogenesisattenuated severityepidemiologyvirus research

Mixed Methods Approach to Examining the Implementation Experience of a Phone-Based Survey for a Sars-Cov-2 Test-Negative Case-Control Study in California. PLoS ONE (2024)

Nozomi FukuiSophia S. LiJennifer DeGuzmanJennifer F. MyersJohn OpenshawAnjali SharmaJames WattJoseph A. LewnardSeema JainKristin L. AndrejkoJake M. Pry

clinical investigationcovid-19implementation experienceinfectious diseasesimplementation researchsars-cov-2respiratory medicinedeployment experienceclinical implementationpublic healthvaccine testingvaccine researchclinical researchsurvey methodologymixed-methods researchepidemiologyvirus research

1
2
3
4
5
15
10 / page

Joseph Lewnard

Associate Professor Assistant Professor

University of California, Berkeley

Affiliations

School of Public Health

Joseph Lewnard is currently serving as a School Of Public Health Associate Professor Assistant Professor at University of California, Berkeley.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Joseph Lewnard

University of California, Berkeley

Associate Professor Assistant Professor

You can click a keyword to filter the displayed items

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Joseph A LewnardVennis HongLindsay R GrantBradley K AckersonKatia J BruxvoortMagdalena PomichowskiAdriano ArguedasAlejandro CanéLuis JodarBradford D GessnerSara Y Tartof

Burden of Bacterial Antimicrobial Resistance in Low-Income and Middle-Income Countries Avertible by Existing Interventions: An Evidence Review and Modelling Analysis. The Lancet (2024)

Joseph A LewnardEsmita CharaniAlec GleasonLi Yang HsuWasif Ali KhanAbhilasha KarkeyClare I R ChandlerTapfumanei MasheEjaz Ahmed KhanAndre N H BulabulaPilar Donado-GodoyRamanan Laxminarayan

Covid-19 Vaccination and Incidence of Pediatric Sars-Cov-2 Infection and Hospitalization. JAMA Network Open (2024)

Jennifer R. HeadPhilip A. CollenderTomás M. LeónLauren A. WhiteSohil R. SudSimon K. CamponuriVivian LeeJoseph A. LewnardJustin V. Remais

virus epidemiologyvaccinationvirologycovid-19vaccinespediatricssars-cov-2respiratory medicinepublic healthepidemiology

Dynamics of Indirect Protection Against Sars-Cov-2 Infection Through Vaccine and Infection-Acquired Immunity. medRxiv (Cold Spring Harbor Laboratory) (2024)

Sophia T. TanIsabel Rodríguez-BarraquerAda T. KwanSeth BlumbergHailey J. ParkJustine HutchinsonDavid LeidnerJoseph A. LewnardDavid SearsNathan C. Lo

Ensuring Progress on Sustainable Access to Effective Antibiotics at the 2024 Un General Assembly: A Target-Based Approach. The Lancet (2024)

Marc MendelsonJoseph A LewnardMike SharlandAislinn CookKoen B PouwelsYewande AlimiMirfin MpunduEvelyn WesangulaJeffrey Scott WeeseJohn-Arne RøttingenRamanan Laxminarayan

Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Lower Respiratory Tract Disease. JAMA Network Open (2024)

vaccinationvaccinesinfectious diseasesvaccine effectivenessrespiratory medicineinfectious respiratory diseasepublic healthvaccine safetyvaccine efficacy

Health Economic Burden Attributable to Novel Serotypes in Candidate 24- and 31-Valent Pneumococcal Conjugate Vaccines. medRxiv (Cold Spring Harbor Laboratory) (2024)

Laura M KingJoseph A Lewnard

vaccinationhealth economicsvaccinesvaccine developmentveterinary medicineinfectious diseaseslaboratory medicinepublic healthhealth sciences

Health-Economic Burden Attributable to Novel Serotypes in Candidate 24- and 31-Valent Pneumococcal Conjugate Vaccines. Vaccine (2024)

Laura M KingJoseph A Lewnard

vaccinationvaccinesvaccine developmenthealth-economic burdennovel serotypespublic healthvaccine research

Immune Escape and Attenuated Severity Associated With the Sars-Cov-2 Ba.2.86/Jn.1 Lineage. Nature Communications (2024)

Joseph A LewnardParag MahaleDebbie MaldenVennis HongBradley K AckersonBruno J LewinRuth Link-GellesLeora R FeldsteinMarc LipsitchSara Y Tartof

virologycovid-19immune escapeinfectious diseasesmicrobial pathogenesissars-cov-2immunologyviral pathogenesisattenuated severityepidemiologyvirus research

Mixed Methods Approach to Examining the Implementation Experience of a Phone-Based Survey for a Sars-Cov-2 Test-Negative Case-Control Study in California. PLoS ONE (2024)

Nozomi FukuiSophia S. LiJennifer DeGuzmanJennifer F. MyersJohn OpenshawAnjali SharmaJames WattJoseph A. LewnardSeema JainKristin L. AndrejkoJake M. Pry

1
2
3
4
5
15
10 / page